Optimization and Validation of Single-Molecule Kinetic Fingerprinting Technology for Rapid, Ultra-Specific Detection of Cancer Mutations

用于快速、超特异性检测癌症突变的单分子动力学指纹技术的优化和验证

基本信息

  • 批准号:
    10000971
  • 负责人:
  • 金额:
    $ 38.84万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2018
  • 资助国家:
    美国
  • 起止时间:
    2018-09-13 至 2021-08-31
  • 项目状态:
    已结题

项目摘要

PROJECT SUMMARY The ultimate vision of this proposal is to develop a technology platform for the direct, rapid, and robust detection of cancer-associated DNA mutations for diagnostics and research. DNA mutations have been known to be fundamental to cancer development for decades and specific fragments of mutated DNA have been sought as non-invasive biomarkers for cancer in blood, stool and other samples. However, a major barrier to progress has been the lack of highly sensitive, specific, and quantitative methods for detecting DNA mutation when mutant DNA fragments are present as rare alleles in a high background of wild-type DNA. We propose here an approach to DNA mutation detection and quantification that is conceptually simple, yet takes advantage of sophisticated and elegant advances in single molecule imaging science. The approach is based on using total internal reflection microscopy to detect the binding and release of a fluorescently-tagged probe to immobilized target DNA molecules on the surface of a glass slide. Differences in nucleotide sequence even at a single nucleotide, give rise to differences in the free energy of hybridization, and this affects the kinetics of binding and release of a probe in a manner that can be detected by single-molecule microscopy. We have already performed proof-of-concept and established feasibility of the approach. In this project, we aim to perform optimizations that will increase sensitivity and increase throughput, and to perform validation with clinical samples from lung cancer patients and controls.
项目摘要 该提案的最终愿景是开发一个技术平台, 用于诊断和研究的癌症相关DNA突变的检测。已知DNA突变 几十年来,突变DNA的特定片段一直是癌症发展的基础, 在血液、粪便和其他样品中寻求作为癌症的非侵入性生物标志物。然而, 目前的进展是缺乏高灵敏度、特异性和定量的DNA突变检测方法 当突变DNA片段作为稀有等位基因存在于野生型DNA的高背景中时。我们提出 这里,一种概念上简单但需要 单分子成像科学的复杂和优雅的进步的优势。该方法是基于 使用全内反射显微镜检测荧光标记探针的结合和释放 固定在载玻片表面的靶DNA分子。核苷酸序列的差异甚至 在单个核苷酸上,引起杂交自由能的差异,这会影响杂交的动力学。 探针的结合和释放可以通过单分子显微镜检测到。我们有 已经进行了概念验证,并确定了该方法的可行性。在这个项目中,我们的目标是 执行优化,以提高灵敏度和吞吐量,并执行验证 来自肺癌患者和对照的临床样品。

项目成果

期刊论文数量(9)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Automatic classification and segmentation of single-molecule fluorescence time traces with deep learning.
  • DOI:
    10.1038/s41467-020-19673-1
  • 发表时间:
    2020-11-17
  • 期刊:
  • 影响因子:
    16.6
  • 作者:
    Li J;Zhang L;Johnson-Buck A;Walter NG
  • 通讯作者:
    Walter NG
A guide to accelerated direct digital counting of single nucleic acid molecules by FRET-based intramolecular kinetic fingerprinting.
  • DOI:
    10.1016/j.ymeth.2021.06.014
  • 发表时间:
    2022-01
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Mandal S;Khanna K;Johnson-Buck A;Walter NG
  • 通讯作者:
    Walter NG
Ultra-photostable DNA FluoroCubes: Mechanism of Photostability and Compatibility with FRET and Dark Quenching.
  • DOI:
    10.1021/acs.nanolett.2c01757
  • 发表时间:
    2022-08-10
  • 期刊:
  • 影响因子:
    10.8
  • 作者:
    Blanchard, Aaron T.;Li, Zi;Duran, Elizabeth C.;Scull, Catherine E.;Hoff, J. Damon;Wright, Keenan R.;Pan, Victor;Walter, Nils G.
  • 通讯作者:
    Walter, Nils G.
Rapid kinetic fingerprinting of single nucleic acid molecules by a FRET-based dynamic nanosensor.
  • DOI:
    10.1016/j.bios.2021.113433
  • 发表时间:
    2021-10-15
  • 期刊:
  • 影响因子:
    12.6
  • 作者:
    Khanna K;Mandal S;Blanchard AT;Tewari M;Johnson-Buck A;Walter NG
  • 通讯作者:
    Walter NG
Direct Kinetic Fingerprinting for High-Accuracy Single-Molecule Counting of Diverse Disease Biomarkers.
  • DOI:
    10.1021/acs.accounts.0c00621
  • 发表时间:
    2021-01-19
  • 期刊:
  • 影响因子:
    18.3
  • 作者:
    Mandal S;Li Z;Chatterjee T;Khanna K;Montoya K;Dai L;Petersen C;Li L;Tewari M;Johnson-Buck A;Walter NG
  • 通讯作者:
    Walter NG
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MUNEESH TEWARI其他文献

MUNEESH TEWARI的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MUNEESH TEWARI', 18)}}的其他基金

Highly specific, amplification-free, single-molecule counting of rare methylated DNA cancer biomarkers
对罕见甲基化 DNA 癌症生物标志物进行高度特异性、无扩增的单分子计数
  • 批准号:
    10025913
  • 财政年份:
    2020
  • 资助金额:
    $ 38.84万
  • 项目类别:
Clinical trial exploring the diet-microbiome axis in allo-HCT patients
探索异基因 HCT 患者饮食-微生物组轴的临床试验
  • 批准号:
    10441583
  • 财政年份:
    2020
  • 资助金额:
    $ 38.84万
  • 项目类别:
Clinical trial exploring the diet-microbiome axis in allo-HCT patients
探索异基因 HCT 患者饮食-微生物组轴的临床试验
  • 批准号:
    10650335
  • 财政年份:
    2020
  • 资助金额:
    $ 38.84万
  • 项目类别:
Clinical trial exploring the diet-microbiome axis in allo-HCT patients
探索异基因 HCT 患者饮食-微生物组轴的临床试验
  • 批准号:
    10241908
  • 财政年份:
    2020
  • 资助金额:
    $ 38.84万
  • 项目类别:
Reference Profiles of ExRNA in Biofluids from Well-Defined Human Cohorts
来自明确定义的人类群体的生物体液中 ExRNA 的参考图谱
  • 批准号:
    8774819
  • 财政年份:
    2014
  • 资助金额:
    $ 38.84万
  • 项目类别:
Reference Profiles of ExRNA in Biofluids from Well-Defined Human Cohorts
来自明确定义的人类群体的生物体液中 ExRNA 的参考图谱
  • 批准号:
    8900333
  • 财政年份:
    2014
  • 资助金额:
    $ 38.84万
  • 项目类别:
Reference Profiles of ExRNA in Biofluids from Well-Defined Human Cohorts
来自明确定义的人类群体的生物体液中 ExRNA 的参考图谱
  • 批准号:
    9125467
  • 财政年份:
    2014
  • 资助金额:
    $ 38.84万
  • 项目类别:
RNA as a Hormone: Systemic Signaling in Mammals via Circulating, Cell-Free Small
RNA 作为激素:哺乳动物中通过循环、无细胞小分子的系统信号传导
  • 批准号:
    7764065
  • 财政年份:
    2009
  • 资助金额:
    $ 38.84万
  • 项目类别:
RNA as a Hormone: Systemic Signaling in Mammals via Circulating, Cell-Free Small
RNA 作为激素:哺乳动物中通过循环、无细胞小分子的系统信号传导
  • 批准号:
    7937011
  • 财政年份:
    2009
  • 资助金额:
    $ 38.84万
  • 项目类别:
RNA as a Hormone: Systemic Signaling in Mammals via Circulating, Cell-Free Small
RNA 作为激素:哺乳动物中通过循环、无细胞小分子的系统信号传导
  • 批准号:
    8325699
  • 财政年份:
    2009
  • 资助金额:
    $ 38.84万
  • 项目类别:

相似海外基金

Linkage of HIV amino acid variants to protective host alleles at CHD1L and HLA class I loci in an African population
非洲人群中 HIV 氨基酸变异与 CHD1L 和 HLA I 类基因座的保护性宿主等位基因的关联
  • 批准号:
    502556
  • 财政年份:
    2024
  • 资助金额:
    $ 38.84万
  • 项目类别:
Olfactory Epithelium Responses to Human APOE Alleles
嗅觉上皮对人类 APOE 等位基因的反应
  • 批准号:
    10659303
  • 财政年份:
    2023
  • 资助金额:
    $ 38.84万
  • 项目类别:
Deeply analyzing MHC class I-restricted peptide presentation mechanistics across alleles, pathways, and disease coupled with TCR discovery/characterization
深入分析跨等位基因、通路和疾病的 MHC I 类限制性肽呈递机制以及 TCR 发现/表征
  • 批准号:
    10674405
  • 财政年份:
    2023
  • 资助金额:
    $ 38.84万
  • 项目类别:
An off-the-shelf tumor cell vaccine with HLA-matching alleles for the personalized treatment of advanced solid tumors
具有 HLA 匹配等位基因的现成肿瘤细胞疫苗,用于晚期实体瘤的个性化治疗
  • 批准号:
    10758772
  • 财政年份:
    2023
  • 资助金额:
    $ 38.84万
  • 项目类别:
Identifying genetic variants that modify the effect size of ApoE alleles on late-onset Alzheimer's disease risk
识别改变 ApoE 等位基因对迟发性阿尔茨海默病风险影响大小的遗传变异
  • 批准号:
    10676499
  • 财政年份:
    2023
  • 资助金额:
    $ 38.84万
  • 项目类别:
New statistical approaches to mapping the functional impact of HLA alleles in multimodal complex disease datasets
绘制多模式复杂疾病数据集中 HLA 等位基因功能影响的新统计方法
  • 批准号:
    2748611
  • 财政年份:
    2022
  • 资助金额:
    $ 38.84万
  • 项目类别:
    Studentship
Recessive lethal alleles linked to seed abortion and their effect on fruit development in blueberries
与种子败育相关的隐性致死等位基因及其对蓝莓果实发育的影响
  • 批准号:
    22K05630
  • 财政年份:
    2022
  • 资助金额:
    $ 38.84万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Genome and epigenome editing of induced pluripotent stem cells for investigating osteoarthritis risk alleles
诱导多能干细胞的基因组和表观基因组编辑用于研究骨关节炎风险等位基因
  • 批准号:
    10532032
  • 财政年份:
    2022
  • 资助金额:
    $ 38.84万
  • 项目类别:
Investigating the Effect of APOE Alleles on Neuro-Immunity of Human Brain Borders in Normal Aging and Alzheimer's Disease Using Single-Cell Multi-Omics and In Vitro Organoids
使用单细胞多组学和体外类器官研究 APOE 等位基因对正常衰老和阿尔茨海默病中人脑边界神经免疫的影响
  • 批准号:
    10525070
  • 财政年份:
    2022
  • 资助金额:
    $ 38.84万
  • 项目类别:
Leveraging the Evolutionary History to Improve Identification of Trait-Associated Alleles and Risk Stratification Models in Native Hawaiians
利用进化历史来改进夏威夷原住民性状相关等位基因的识别和风险分层模型
  • 批准号:
    10689017
  • 财政年份:
    2022
  • 资助金额:
    $ 38.84万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了